Search by year - Any -2024202320222021202020192018201720162015 5 November 2024 Biocartis appoints Randy Polonsky as CFO Non-regulated information 23 October 2024 Biocartis announces six Idylla abstracts to be presented at AMP 2024 Annual Meeting Non-regulated information 13 August 2024 Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer Non-regulated information 10 June 2024 Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Non-regulated information 6 May 2024 Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Non-regulated information 22 November 2023 Recapitalization Completed and Product Portfolio Expansion Non-regulated information 13 November 2023 Biocartis Hosts Corporate Workshop and Announces Seven Idylla Abstracts to be Presented at AMP 2023 Annual Meeting Non-regulated information 16 October 2023 Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Non-regulated information 12 October 2023 Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Non-regulated information 28 August 2023 Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders Non-regulated information Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »